Illumina, Inc. (ILMN) Revenue by Segment

Illumina revenue by segment at a glance

In Q2 fiscal 2026 (the quarter ended June 28, 2026), Illumina's largest business segment was Sequencing, with $1.05 billion or 91% of revenue, up 8.4% from a year earlier. Next: Microarray (9%).

By product or service, Product brought in 85% and Service brought in 15% of revenue in Q2 fiscal 2026.

By region, United States and Canada brought in 56%, EMEA brought in 32% and Asia Pacific brought in 7% of revenue in Q2 fiscal 2026.

The fastest-growing business segment from a year earlier was Microarray (+20.7%).

From company filings, in USD; latest quarter ended June 28, 2026; quarterly data from Q3 fiscal 2017.

Illumina, Inc.

ILMNHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

SequencingMicroarrayCore IlluminaConsolidated Variable Interest EntitiesGRAIL, Inc.

Q2 FY26 breakdown

Fiscal quarter ended Jun 28, 2026

Item	Revenue	Share	vs year before	Trend
Sequencing	USD 1.05B	90.9%	+8.4%
Microarray	USD 105.00M	9.1%	+20.7%

Sum of items USD 1.16B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18	Q4 FY17	Q3 FY17
Sequencing	1.1B	995.0M	1.1B	1.0B	972.0M	947.0M	1.0B	995.0M	1.0B	979.0M	1.0B	1.0B	1.1B	976.0M	982.0M	1.0B	1.1B	1.1B	1.1B	1.0B	1.0B	979.0M	845.0M	708.0M	566.0M	760.0M	836.0M	805.0M	728.0M	699.0M	–	719.0M	690.0M	630.0M	–	–
Microarray	105.0M	96.0M	94.0M	83.0M	87.0M	94.0M	101.0M	85.0M	96.0M	97.0M	98.0M	90.0M	93.0M	111.0M	102.0M	100.0M	97.0M	114.0M	105.0M	93.0M	105.0M	114.0M	108.0M	86.0M	67.0M	99.0M	116.0M	102.0M	110.0M	147.0M	–	134.0M	140.0M	152.0M	–	–
Core Illumina	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	715.0M
Consolidated Variable Interest Entities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.0M	–	–	–	–	–	1.0M
GRAIL, Inc.	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.0M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Illumina revenue by business segment, last 4 quarters

Business segment	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Sequencing	$1.1B	$995.0M	$1.0B	$972.0M	91%
Microarray	$105.0M	$96.0M	$83.0M	$87.0M	9%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Illumina revenue by product or service, last 4 quarters

Product or service	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Product	$982.0M	$917.0M	$927.0M	$912.0M	85%
Service	$177.0M	$174.0M	$157.0M	$147.0M	15%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Illumina revenue by region, last 4 quarters

Region	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
United States and Canada	$653.0M	$590.0M	–	$569.0M	56%
EMEA	$368.0M	$356.0M	–	$355.0M	32%
Asia Pacific	$82.0M	$93.0M	–	$72.0M	7%
China	$56.0M	$52.0M	$52.0M	$63.0M	5%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Questions and answers

What are Illumina's business segments?

Sequencing and Microarray (as reported for Q2 fiscal 2026).

Which business segment makes the most money for Illumina?

Sequencing: $1.05 billion, or 91% of revenue, in Q2 fiscal 2026.

What are Illumina's main products and services?

By revenue in Q2 fiscal 2026: Product (85%) and Service (15%).

Where does Illumina make its money?

By region in Q2 fiscal 2026: United States and Canada (56%), EMEA (32%), Asia Pacific (7%) and China (5%).

MoreIllumina stock overview Illumina financials Illumina executive team Illumina shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

SequencingMicroarrayCore IlluminaConsolidated Variable Interest EntitiesGRAIL, Inc.

Q2 FY26 breakdown

Fiscal quarter ended Jun 28, 2026

Item	Revenue	Share	vs year before	Trend
Sequencing	USD 1.05B	90.9%	+8.4%
Microarray	USD 105.00M	9.1%	+20.7%

Sum of items USD 1.16B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18	Q4 FY17	Q3 FY17
Sequencing	1.1B	995.0M	1.1B	1.0B	972.0M	947.0M	1.0B	995.0M	1.0B	979.0M	1.0B	1.0B	1.1B	976.0M	982.0M	1.0B	1.1B	1.1B	1.1B	1.0B	1.0B	979.0M	845.0M	708.0M	566.0M	760.0M	836.0M	805.0M	728.0M	699.0M	–	719.0M	690.0M	630.0M	–	–
Microarray	105.0M	96.0M	94.0M	83.0M	87.0M	94.0M	101.0M	85.0M	96.0M	97.0M	98.0M	90.0M	93.0M	111.0M	102.0M	100.0M	97.0M	114.0M	105.0M	93.0M	105.0M	114.0M	108.0M	86.0M	67.0M	99.0M	116.0M	102.0M	110.0M	147.0M	–	134.0M	140.0M	152.0M	–	–
Core Illumina	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	715.0M
Consolidated Variable Interest Entities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.0M	–	–	–	–	–	1.0M
GRAIL, Inc.	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.0M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–